Emergent Biosolutions
EBS
EBS
340 hedge funds and large institutions have $4.13B invested in Emergent Biosolutions in 2021 Q1 according to their latest regulatory filings, with 42 funds opening new positions, 126 increasing their positions, 138 reducing their positions, and 50 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
340
Holders Change
-13
Holders Change %
-3.68%
% of All Funds
5.99%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
42
Increased
126
Reduced
138
Closed
50
Calls
$12.8M
Puts
$12.8M
Net Calls
-$36K
Net Calls Change
-$209K
Top Buyers
Top Sellers
| 1 |
1
Goldman Sachs
New York
|
$44.4M |
| 2 |
2
Norges Bank
Oslo,
Norway
|
$26.5M |
| 3 |
3
State Street
Boston,
Massachusetts
|
$178M |
| 4 |
4
Jennison Associates
New York
|
$15.1M |
| 5 |
5
Fidelity Investments
Boston,
Massachusetts
|
$23.7M |
